Journal article
Venetoclax: a primer
Andrew W Roberts
Blood Advances | AMER SOC HEMATOLOGY | Published : 2017
Grants
Funding Acknowledgements
A.W.R. received research funding from AbbVie and Genentech, the codevelopers of venetoclax; and is an employee of the Walter and Eliza Hall Institute of Medical Research, which receives royalty income related to venetoclax. A.W.R. has no personal financial interest in venetoclax. He has also received research funding from Janssen and Servier.